Cargando…
CD146 is closely associated with the prognosis and molecular features of osteosarcoma: Guidance for personalized clinical treatment
Background: Osteosarcoma (OSA), a focus for orthopedic surgeons, always results in severe death due to metastasis. CD146 is severely expressed in several tumors, indicating its potential as a biomarker for OSA. Method: Two OSA cohorts were enrolled in this study. A Therapeutically Applicable Researc...
Autores principales: | Wang, Jingkun, Wu, Zhonghan, Zheng, Meige, Yu, Shuisheng, Zhang, Xin, Xu, XinZhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635853/ https://www.ncbi.nlm.nih.gov/pubmed/36338992 http://dx.doi.org/10.3389/fgene.2022.1025306 |
Ejemplares similares
-
A Novel Pyroptosis-Related Signature for Predicting Prognosis and Indicating Immune Microenvironment Features in Osteosarcoma
por: Zhang, Yiming, et al.
Publicado: (2021) -
Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma
por: Westrøm, Sara, et al.
Publicado: (2016) -
Recognize the role of CD146/MCAM in the osteosarcoma progression: an in vitro study
por: Lei, Xing, et al.
Publicado: (2021) -
Prediction of Prognosis and Immunotherapy of Osteosarcoma Based on Necroptosis-Related lncRNAs
por: Wang, Guowei, et al.
Publicado: (2022) -
Analysis of Immune–Stromal Score-Based Gene Signature and Molecular Subtypes in Osteosarcoma: Implications for Prognosis and Tumor Immune Microenvironment
por: Zheng, Dingzhao, et al.
Publicado: (2021)